hengrui glp 1 Jiangsu and Kailera report positive topline data for 8mg HRS9531 GLP-1/GIP China Challenges GLP-1 Leaders, ㅤ,
Pay in 4 interest-free payments of $5.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
China Challenges GLP 1 Leaders, , Kailera licensed a portfolio of obesity therapies from China's Jiangsu Hengrui, including a Phase 3 GLP 1 candidate that delivered up to 10.9% average weight loss at Hengrui's GLP 1 GIP agonist posts 18% weight loss in phase 3 trial Hengrui Pharma and Kailera Therapeutics Report Positive Topline Data from Phase 3 Obesity Trial in China of Dual GLP 1 GIP Receptor Agonist HRS9531 Tue, 07 15 2025 08:00 Hengrui, Kailera's oral GLP 1 clears late stage bar in China but US results still pending BioSpace BioCentury Hengrui and Kailera's oral obesity pill in line with competition
Store: skorenge.com · Domain: skorenge.com

















![[ma:nyo] Glutathione 7 Dark Spot Serum 30ml](http://manyo.us/cdn/shop/files/11-2026-04-01T104502.779.png?v=1775065626)







